Edition:
India

Catabasis Pharmaceuticals Reports Q2 Loss Per Share $0.62


Thursday, 8 Aug 2019 

Aug 8 (Reuters) - Catabasis Pharmaceuticals Inc ::CATABASIS PHARMACEUTICALS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND REVIEWS BUSINESS PROGRESS.Q2 LOSS PER SHARE $0.62.Q2 EARNINGS PER SHARE ESTIMATE $-0.61 -- REFINITIV IBES DATA.CATABASIS PHARMACEUTICALS - AS OF JUNE 30, CO HAD CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $46.1 MILLION, VERSUS $51.7 MILLION AS OF MARCH 31, 2019.EXPECTS THAT IT HAS SUFFICIENT CASH TO FUND OPERATIONS BEYOND TOP-LINE PHASE 3 RESULTS AND THROUGH 2020. 

Company Quote

4.9
0.0 +0.00%
14 Oct 2019